source
- Madrigal's Rezdiffra sales top forecasts as Gilead announces job cutsMadrigal Pharmaceuticals reported first‑quarter sales of its MASH drug Rezdiffra at $311 million, roughly $10 million above analyst expectations, according to TD Cowen. The outperformance highligh…
- Former Orbital scientists launch ParcelBio with $13 million seed round to boost mRNA therapy durabilityTwo former Orbital Therapeutics scientists, Chris Carlson and David Weinberg, have founded a new company called ParcelBio. The startup aims to address a technical limitation that has hindered the…